Research & Development Conference-
Date
October 27, 2009
-
Location
Harvard Medical School
Joseph B. Martin Conference Center 77 Avenue Louis Pasteur
Boston, MA 02115
-
Cost
$895 per person
$1200 per presenting company
(includes speaker & 2 attendees) -
Sponsors
-
Register Online
Click here to sign up
No refunds will be issued
for canceled registrations. -
Dress Code
Business Attire
| Time | Presenter |
|---|---|
| 8:30 - 9:00 am | Michelle Dipp, GSK, Centre of Excellence for External Drug Discovery |
| 9:00 - 9:30 am | John Maraganore, Alnylam Pharmaceuticals |
| 9:30 - 10:00 am | John Santini, MicroCHIPS, Inc. |
| 10:00 - 10:30 am | Leland Webster, Tetraphase Pharmaceuticals, Inc. |
| 10:30 - 11:00 am | Laurence Reid, Ensemble Discovery, Inc. |
| 11:00 - 11:30 am | Duncan Higgons, Agios Pharmaceuticals |
| 11:30 - 12:00 pm | Sandra Luikenhuis, PPD Dermatology, Inc. |
| 12:00 - 12:30 pm | VC Panel |
| 12:30 - 1:00 pm | |
| 1:00 - 1:30 pm | Mark Bodmer, GSK, Metabolic Pathways Drug Discovery |
| 1:30 - 2:00 pm | Matthias Jaffe, Zafgen |
| 2:00 - 2:30 pm | Buyside Panel |
| 2:30 - 3:00 pm | Colin Hill, Gene Network Sciences |
| 3:00 - 3:30 pm | |
| 3:30 - 4:00 pm | Therapeutic Area Panel |
| 4:00 - 4:30 pm | Ryo Kubota, Acucela |
| Time | Presenter |
|---|---|
| 8:30 - 9:00 am | Mike Gray, Curis, Inc. |
| 9:00 - 9:30 am | Roger Tung, Concert Pharmaceuticals |
| 9:30 - 10:00 am | Neil Exter, Constellation Pharmaceuticals |
| 10:00 - 10:30 am | Brian Gallagher, Sirtris, a GSK Company |
| 10:30 - 11:00 am | JC Gutierrez-Ramos, GSK, Immuno-Inflammation Drug Discovery |
| 11:00 - 11:30 am | Helen Marie Nugent, Pervasis Therapeutics, Inc. |
| 11:30 - 12:00 pm | Spiros Jamas, Tempero Pharmaceuticals |
| 12:00 - 12:30 pm | |
| 12:30 - 1:00 pm | |
| 1:00 - 1:30 pm | |
| 1:30 - 2:00 pm | |
| 2:00 - 2:30 pm | |
| 2:30 - 3:00 pm | Kevin Judice, Achaogen |
| 3:00 - 3:30 pm | |
| 3:30 - 4:00 pm | |
| 4:00 - 4:30 pm |
| Name | Company |
|---|---|
| Name | Company |
|---|
| Time | Presenter | Moderator |
|---|---|---|
| 8:00 – 8:20 am | Introduction | Dean Jeffrey S. Flier, MD, Harvard Medical School |
| 8:20 – 9:00 am | Zafgen | Charles Duncan, JMP |
| 9:00 – 9:40 am | Curis | Ren Benjamin, Rodman & Renshaw |
| 9:40 – 10:20 am | Pulmatrix | Michael King, Rodman & Renshaw |
| 10:20 – 11:00 am | Pervasis | Michael King, Rodman & Renshaw |
| 11:00 – 11:40 am | Robert Langer, Ph.D. - Exciting Opportunities in Drug Delivery | Tom Shrader, Rodman & Renshaw |
| 11:40 am – 12:20 pm | Solace | Charles Duncan, JMP |
| 12:20 – 1:00 pm | Eric S. Lander - Genomics and Medicine | Michael King, Rodman & Renshaw |
| 1:00 – 1:40 pm | Frederick W. Alt, Ph.D. | Michael King, Rodman & Renshaw |
| 1:40 – 2:20 pm | Genocea | Michael King, Rodman & Renshaw |
| 2:20 – 3:00 pm | Aveo | Edward Tenthoff, Piper Jaffray |
| 3:00 – 3:40 pm | Magen | Michael King, Rodman & Renshaw |
| 3:40 – 4:20 pm | Trubion | Matthew Osborne, Lazard Capital |
| 4:20 – 5:00 pm | Christopher T. Walsh, Ph.D. - Antibiotics: Current Challenges | Matthew Osborne, Lazard Capital |
| 5:00 – 5:20 pm | Agios | Matthew Osborne, Lazard Capital |
| 5:40 – 6:20 pm | Sirtris | Michael King, Rodman & Renshaw |
| Time | Presenter | Moderator |
|---|---|---|
| 8:00 – 8:20 am | Introduction - Room A | Dean Jeffrey S. Flier, MD, Harvard Medical School |
| 8:20 – 9:00 am | Leonard Guarente, Ph.D. - Sirtuins, Aging and Disease | Eric Schmidt, SG Cowen |
| 9:00 – 9:40 am | Hydra | Eric Schmidt, SG Cowen |
| 9:40 – 10:20 am | Barbara Kahn, M.D. - Tackling the Epidemic of Diabetes and Obesity | Tom Shrader, Rodman & Renshaw |
| 10:20 – 11:00 am | Pervasis | Michael King, Rodman & Renshaw |
| 11:00 – 11:40 am | Phillip A. Sharp, Ph.D. - Treatment by RNA and of RNA | Michael King, Rodman & Renshaw |
| 11:40 am – 12:20 pm | Buyside Panel (Andrea Bici, Tom Brakel, Stephen DuBois, Gary Hatton, Peter Kolchinsky, Adam Koppel, Jay Markowitz, and Hans Von Der Luft) | Richard Aldrich |
| 12:20 – 1:00 pm | David A. Sinclar, Ph.D. - Discovering Medicines that Treat Multiple Diseases of Aging | Michael King, Rodman & Renshaw |
| 1:00 – 1:40 pm | TheraGenetics | Michael King, Rodman & Renshaw |
| 1:40 – 2:20 pm | Threshold | Michael King, Rodman & Renshaw |
| 2:20 – 3:00 pm | Concert | Michael King, Rodman & Renshaw |
| 3:00 – 3:40 pm | Dicerna | Edward Tenthoff, Piper Jaffray |
| 3:40 – 4:20 pm | Constellation | Michael King, Rodman & Renshaw |
| 4:20 – 5:00 pm | NeurAxon | Michael King, Rodman & Renshaw |
| 5:00 – 5:20 pm | Venture Capital Panel (Ben Auspitz, Bruce Booth, Doug Fambrough, Jean George, Campbell Murray) | Doug Cole |
| 5:40 – 6:20 pm | Targanta | Charles Duncan, JMP |
| Name | Address | Phone |
|---|---|---|
| The Charles Hotel | One Bennett Street, Cambridge, MA | (617) 864-1200 |
| The Liberty Hotel | 215 Charles Street, Boston, MA | (857) 233-0552 |
| Le Meridien Cambridge | 20 Sidney Street, Cambridge, MA | (617) 577-0200 |
| The Kendall Hotel | 350 Main Street, Cambridge, MA | (857) 233-0552 |
| The Marriott Cambridge Center | Two Cambridge Center, 50 Broadway, Cambridge, MA | (617) 494-6600 |
| The Doubletree Guest Suites Boston | 400 Soldiers Field Road, Boston, MA | (617) 783-0090 |
Business Development Conference-
Date
April 13th, 2010
-
Location
The Charles Hotel One Bennett Street
Cambridge, MA
800.882.1818 -
Cost
$895 per person
-
Sponsors
-
Register Online
Click here to sign up
No refunds will be issued
for canceled registrations. -
Dress Code
Business Attire
| Time | Presenter |
|---|---|
| TBD | Agenda will be similar to 2009. |
| Name | Company |
|---|---|
| Name | Company |
|---|---|
| Rich Aldrich | RA Capital |
| Naseem Amin | Biogen Idec |
| Mike Bigham | Abingworth |
| Robert Bagdorf | Pfizer |
| Michelle Dipp | GSK CEEDD |
| Richard Douglas | Genzyme |
| J.F. Formela | Atlas Venture |
| Barry Greene | Alnylam |
| Steve Krognes | Roche |
| Mark Miller | Eli Lilly and Company |
| Adelene Perkins | Infinity |
| David Pyott | Allergan |
| Ad Rawcliffe | GSK |
| Catherine Sazdanoff | Takeda |
| Alain Vertes | Roche |
| Christoph Westphal | Sirtris, a GSK Company |
| Barbara Yanni | Merck & Co. |
| Time | Presenter |
|---|---|
| 7:30 – 8:00 am | Networking Breakfast |
| 8:00 – 8:15 am | Bob Coughlin, President, Mass Biotech Council; Chris Gabrieli, Co-Founder and Chairman, Massachusetts 2020 Foundation; and John Maraganore, CEO, Alnylam |
| 8:15 – 8:30 am | Wyc Grousbeck, CEO & Owner, Boston Celtics |
| 8:30 – 8:50 am | David Pyott, CEO, Allergan (Moderator: Scott Kirsner, Boston Globe) |
| 8:50 – 9:00 am | David Meeker, EVP, Genzyme |
| 9:00 – 9:40 am | Small Biotech Panel (Moderator: Adelene Perkins, Infinity - Panel: Steve Bernitz, Robert Gallotto, Duncan Higgons, Tom Hughes, Jason Rhodes and Craig Wheeler) |
| 9:40 – 10:00 am | Barry Greene, President and COO, Alnylam - Large Pharma Deals and Spinouts (Moderator: George Vlasuk, Sirtris, a GSK Company) |
| 10:00 – 10:40 am | Wall Street Panel (Moderator: Mike King, Rodman & Renshaw - Panel: Bob Carey, Charles Duncan, Howard Liang, Mark Schoenebaum, Jamie Streator and Andrew Weisenfeld) |
| 10:40 – 11:00 am | Networking Break |
| 11:00 – 11:40 am | Large Biotech Panel (Moderator: Ellen Baron, Oxford Bioscience Partners - Panel: Naseem Amin, Richard Douglas, Jeremy Goldberg, and Anna Protopapas) |
| 11:40 – 12:00 pm | Alain Vertes, Global Alliance Director, Roche (Moderator: Mike King, Rodman & Renshaw) |
| 12:00 – 12:30 pm | Lunch Keynote: Ad Rawcliffe, S.V.P., Worldwide Business Development, GlaxoSmithKline (Moderator: Rich Aldrich, RA Capital) |
| 12:30 – 1:10 pm | VC Panel (Moderator: J.F. Formela, Atlas Venture - Panel: Alex Barkas, Mike Bigham, Doug Cole, Joel Marcus, Ed Mathers and Greg Weinhoff) |
| 1:10 – 1:30 pm | Barbara Yanni, V.P. and Chief Licensing Officer, Merck & Co. (Moderator: Mike King, Rodman & Renshaw) |
| 1:30 – 1:50 pm | Christoph Westphal, CEO, Sirtris, a GSK Company and Ed Mathers, Partner, New Enterprise Associates (Moderator: Jim Tananbaum, Prospect Venture Partners) |
| 1:50 – 2:30 pm | Pharma Panel (Moderator: Barbara Kosacz, Cooley Godward Kronish - Panel: Robert Bagdorf, Michelle Dipp, Jeff Elton, Thomas Hofstaetter, Brian McVeigh, Mark Miller, and Alain Vertes) |
| Name | Address | Phone |
|---|---|---|
| The Charles Hotel | One Bennett Street, Cambridge, MA | (617) 864-1200 |
| The Liberty Hotel | 215 Charles Street, Boston, MA | (857) 233-0552 |
| Le Meridien Cambridge | 20 Sidney Street, Cambridge, MA | (617) 577-0200 |
| The Kendall Hotel | 350 Main Street, Cambridge, MA | (857) 233-0552 |
| The Marriott Cambridge Center | Two Cambridge Center, 50 Broadway, Cambridge, MA | (617) 494-6600 |
| The Doubletree Guest Suites Boston | 400 Soldiers Field Road, Boston, MA | (617) 783-0090 |
CEO Conference -
Date
June 15th, 2010
-
Location
The Charles Hotel One Bennett Street
Cambridge, MA
800.882.1818 -
Cost
$895 per person
-
Sponsors
-
Register Online
Click here to sign up
No refunds will be issued
for canceled registrations. -
Dress Code
Business Attire
| Time | Presenter |
|---|---|
| TBD | Agenda will be similar to 2009. |
| Name | Company |
|---|---|
| Name | Address | Phone |
|---|---|---|
| The Charles Hotel | One Bennett Street, Cambridge, MA | (617) 864-1200 |
| The Liberty Hotel | 215 Charles Street, Boston, MA | (857) 233-0552 |
| Le Meridien Cambridge | 20 Sidney Street, Cambridge, MA | (617) 577-0200 |
| The Kendall Hotel | 350 Main Street, Cambridge, MA | (857) 233-0552 |
| The Marriott Cambridge Center | Two Cambridge Center, 50 Broadway, Cambridge, MA | (617) 494-6600 |
| The Doubletree Guest Suites Boston | 400 Soldiers Field Road, Boston, MA | (617) 783-0090 |
| Name | Company |
|---|---|
| Rich Aldrich | Chairman, Alnara Pharmaceuticals |
| Josh Boger | Former CEO, Vertex Pharmaceuticals |
| Deborah Dunsire | CEO, Millennium Pharmaceuticals |
| Matthew Emmens | CEO, Vertex Pharmaceuticals |
| Tuan Ha-Ngoc | CEO, AVEO Pharmaceuticals |
| Steve Holtzman | CEO, Infinity Pharmaceuticals |
| John Maraganore | CEO, Alnylam Pharmaceuticals |
| David Mott | General Partner, New Enterprise Associates and Former CEO, MedImmune |
| Jim Mullen | CEO, Biogen Idec |
| Brian Pereira | CEO, AMAG Pharmaceuticals |
| Richard Pops | Chairman, Alkermes |
| Mark Skaletsky | Chairman, AMAG Pharmaceuticals |
| Henri Termeer | CEO, Genzyme |
| Roger Tung | CEO, Concert Pharmaceuticals |
| Christoph Westphal | CEO, Sirtris, a GSK Company |
| Time | Presenter |
|---|---|
| 7:30 – 8:00 am | Networking Breakfast |
| 8:00 – 8:10 am | Introduction by Christoph Westphal, CEO, Sirtris, a GSK Company, and Henri Termeer, CEO, Genzyme |
| 8:10 – 8:20 am | Bob Coughlin, President, Mass Biotech Council |
| 8:20 – 9:00 am | Small Biotech Panel (Moderator: John Maraganore - Panel: Steve Holtzman, Steve Kaldor, Brian Pereira, Roger Tung, and Christoph Westphal) |
| 9:00 – 9:15 am | Networking Break |
| 9:15 – 9:45 am | Moncef Slaoui, Chairman, Research and Development, GSK |
| 9:45 – 10:25 am | Large Biotech Panel (Moderator: Steve Burrill - Panel: Josh Boger, Deborah Dunsire, Richard Pops, and Henri Termeer) |
| 10:25 – 10:45 am | Keynote Speaker: Bob Greifeld, CEO, The NASDAQ OMX Group |
| 10:45 – 11:15 am | Networking Break |
| 11:15 – 11:35 am | Greg Lucier, CEO, Invitrogen Corporation |
| 11:35 – 12:00 pm | Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA |
| 12:00 – 12:30 pm | Keynote Speaker: Mark McClellan, Former Head, FDA; Former Head, CMS; Director, Engelberg Center for Health Care Reform, Brookings Institution |
| 12:30 – 1:30 pm | Networking Lunch |
| 1:30 – 2:00 pm | VC Panel (Moderator: Laura Berezin - Panel: Mike Bigham, Jens Eckstein, Ansbert Gadicke, Hingge Hsu, Kyle Lefkoff, and David Mott) |
| 2:00 – 2:30 pm | General Discussion: Henri Termeer, CEO, Genzyme and Christoph Westphal, CEO, Sirtris, a GSK Company |